FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21291211000001106: Ruxolitinib phosphate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    70960501000001115 Ruxolitinib phosphate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    70960601000001116 Ruxolitinib phosphate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Ruxolitinib phosphate Is a Substance with protein-tyrosine kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ruxolitinib 15mg tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 20mg tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 5mg tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 15mg tablets 60 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 5mg tablets 60 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 20mg tablets 60 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd) 60 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 5mg tablets 56 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 20mg tablets 56 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 15mg tablets 56 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Product containing precisely ruxolitinib 5 milligram/1 each conventional release oral tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Ruxolitinib 10mg tablets 56 tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Product containing precisely ruxolitinib 10 milligram/1 each conventional release oral tablet Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier
    Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Ruxolitinib phosphate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start